SL
Insider selling
Sung Lee sold $266K of Cytokinetics Inc (CYTK) stock
Sung Lee, EVP, Chief Financial Officer of Cytokinetics Inc (CYTK), sold 3,134 shares of CYTK stock worth $266K, per an SEC Form 4 filed Jun 29, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade was reported on Jun 29, 2026.
CYTK has moved -22.6% since the trade date, from $87.26 to $67.56 (Sep 21, 2026 close).
- Traded
- Jun 29, 2026
- Disclosed
- Jun 29, 2026
- Filing delay
- 0 days
- Price since
- -22.6%
- Role
- EVP, Chief Financial Officer
- Source
- SEC Form 4
More CYTK insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.